Physician

Roger John Klein, M.D.

According to 2025 Medicare claims, Roger Klein, M.D. (NPI: 1205947868) practices cardiology in the Huntington-Ashland, WV-KY-OH market, with the plurality of this provider's patient population coming from Greenup, KY. This provider's primary affiliated billing organization is KINGS DAUGHTERS MEDICAL SPECIALTIES INC. (NPI: 1134484892; TIN: 264183569) and primary practice location at 41101-2843.

Klein's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,414 traditional Medicare patients, billed 2,617 HCPCS/CPT codes, and received $90,913 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,709 prescription claims across 453 beneficiaries totaling $339,366 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 33 claims. Open Payments data shows 53 records totaling $659. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $269,554 to $90,913. Similarly, Part D prescription costs have declined steadily, from $874,685 to $339,366. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $23,962 and ending at $6,988.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,133	5,651	$269,554
2016	2,293	5,914	$261,971
2017	3,155	7,455	$251,486
2018	2,970	6,975	$235,512
2019	2,878	6,993	$261,164
2020	1,967	4,787	$218,976
2021	1,422	3,500	$178,026
2022	1,415	3,195	$147,313
2023	1,415	2,991	$118,178
2024	1,414	2,617	$90,913

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	690	12,853	$874,685
2016	704	9,388	$584,537
2017	683	7,151	$476,889
2018	676	6,216	$451,327
2019	625	4,672	$365,275
2020	571	4,294	$336,814
2021	495	3,471	$398,494
2022	502	3,830	$508,512
2023	491	3,509	$486,707
2024	453	2,709	$339,366

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	95	584	$19,892
2016	85	464	$44,351
2017	36	319	$5,691
2018	N/R	63	$1,099
2019	N/R	92	$2,758
2020	N/R	63	$43,431
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	11	33	$80,669
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	139	174	$66
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	135	248	$58
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	267	270	$49
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	255	389	$42
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	939	1,066	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	97	5,350	$102,546
Xarelto	Rivaroxaban	72	4,477	$80,024
Entresto	Sacubitril/Valsartan	44	1,890	$42,979
Jardiance	Empagliflozin	25	1,110	$21,455
Repatha Sureclick	Evolocumab	17	868	$16,658

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	53	$659	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Roger John Klein, M.D.?

Tedicare shows public-source Medicare data for Roger John Klein, M.D. (NPI 1205947868), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Roger John Klein, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Roger John Klein, M.D.?

Roger John Klein, M.D. is linked to KINGS DAUGHTERS MEDICAL SPECIALTIES INC. (billing NPI 1134484892) in the available physician profile data.

Does Roger John Klein, M.D. have Open Payments data?

Roger John Klein, M.D. has 53 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.